XSC
MRK icon

X-Square Capital’s Merck MRK Stock Holding History

X-Square Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$572K Buy
4,449
+300
+7% +$35.1K 0.15% 126
2026
Q1 		$499K Buy
4,149
+31
+0.8% +$3.58K 0.17% 125
2025
Q4 		$434K Sell
4,118
-89
-2% -$8.36K 0.14% 127
2025
Q3 		$353K Sell
4,207
-297
-7% -$24.5K 0.11% 132
2025
Q2 		$357K Buy
4,504
+2
+0% +$159 0.13% 131
2025
Q1 		$404K Buy
4,502
+2
+0% +$187 0.17% 116
2024
Q4 		$448K Buy
4,500
+1
+0% +$103 0.18% 114
2024
Q3 		$511K Buy
4,499
+11
+0.2% +$1.31K 0.22% 102
2024
Q2 		$556K Hold
4,488
– – 0.26% 95
2024
Q1 		$580K Buy
4,488
+3
+0.1% +$370 0.27% 94
2023
Q4 		$489K Buy
4,485
+416
+10% +$43.2K 0.27% 104
2023
Q3 		$469K Hold
4,069
– – 0.32% 93
2023
Q2 		$469K Sell
4,069
-499
-11% -$56.7K 0.32% 93
2023
Q1 		$486K Buy
4,568
+1
+0% +$108 0.29% 101
2022
Q4 		$507K Buy
4,567
+300
+7% +$30.7K 0.29% 101
2022
Q3 		$367K Buy
4,267
+1
+0% +$89 0.23% 110
2022
Q2 		$389K Buy
4,266
+1
+0% +$89 0.23% 105
2022
Q1 		$350K Sell
4,265
-25
-0.6% -$1.97K 0.18% 117
2021
Q4 		$329K Buy
4,290
+211
+5% +$16.8K 0.17% 121
2021
Q3 		$306K Buy
4,079
+420
+11% +$31.9K 0.16% 122
2021
Q2 		$285K Sell
3,659
-149
-4% -$11.1K 0.14% 121
2021
Q1 		$280K Buy
3,808
+165
+5% +$12.2K 0.13% 101
2020
Q4 		$284K Hold
3,643
– – 0.15% 94
2020
Q3 		$288K Hold
3,643
– – 0.21% 79
2020
Q2 		$269K Buy
3,643
+632
+21% +$47.6K 0.19% 72
2020
Q1 		$221K Hold
3,011
– – 0.22% 66
2019
Q4 		$261K Buy
3,011
+183
+6% +$15K 0.15% 68
2019
Q3 		$227K Buy
+2,828
New +$227K 0.14% 67

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

X-Square Capital's MRK Position: Q2 2026 in Review

X-Square Capital increased its Merck (MRK) stake by 7.2% in Q2 2026, buying an estimated $35.1K and bringing the position to 4,449 shares worth $572K. The position accounts for 0.15% of the portfolio, ranked #126.

X-Square Capital first reported a position in MRK in Q3 2019 and has held it in 28 quarters since. The position peaked at $580K in Q1 2024. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • X-Square Capital held 4,449 shares of Merck worth $572K as of Q2 2026.
  • X-Square Capital bought 300 Merck shares in Q2 2026, an estimated $35.1K.
  • Merck made up 0.15% of X-Square Capital's portfolio in Q2 2026, its #126 holding.
  • X-Square Capital first reported a position in Merck in Q3 2019 and has held it in 28 quarters since.
  • X-Square Capital's Merck position peaked at $580K in Q1 2024.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on X-Square Capital's 13F filing for Q2 2026, filed 12 Aug 2026.